SAN DIEGO -- Treatment with eltrombopag (Promacta) for pediatric patients with newly diagnosed immune thrombocytopenia (ITP) led to a significantly higher rate of durable platelet response compared ...

A panelist discusses how personalized ITP care requires open conversations about testing costs, insurance coverage, and treatment accessibility, with clinicians helping patients navigate financial ...

Children with newly diagnosed immune thrombocytopenia (ITP) treated with eltrombopag as a frontline therapy show significantly improved platelet responses and other outcomes compared with the standard ...

Please provide your email address to receive an email when new articles are posted on . Patients with immune thrombocytopenia achieved durable platelet count expansion with rilzabrutinib.

Adding ianalumab to standard-of-care second-line eltrombopag prolonged the time to treatment failure vs placebo plus eltrombopag in patients with primary immune thrombocytopenia (ITP) in the pivotal ...

An expert discusses the importance of patient education and personalized, flexible treatment planning in managing chronic immune thrombocytopenic purpura (ITP), highlighting proactive strategies like ...

"Care of the elderly has become its own science and is very different in virtually everything than is the care of a typical middle-aged adult. This is important for ITP." — James Bussel, MD Reflecting ...

While following any prescribed treatment is important, there are also vital steps you can take on your own to keep this blood disorder in check. Living with chronic immune thrombocytopenia (ITP), a ...

Have you ever felt like your body isn’t quite playing by the rules? Living with Immune Thrombocytopenia (ITP) can sometimes feel like an unpredictable journey, with fluctuating platelet levels and ...